Vericel (VCEL) Revenue (2011 - 2026)
Vericel (VCEL) reported Revenue of $68.4 million for Q1 2026, up 30.09% on a YoY basis from $52.6 million in Q1 2025, and down 26.36% sequentially from $92.9 million in Q4 2025.
Vericel (VCEL) Revenue (2011 - 2026) Analysis & Trends
Vericel (VCEL) has 16 years of Revenue data on file, last reported at $68.4 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 30.09% year-over-year to $68.4 million; the trailing twelve-month figure through Mar 2026 stood at $292.1 million (up 22.45% YoY), and the FY2025 full-year result was $276.3 million, up 16.45% from the prior year.
- Revenue eased to $68.4 million in Q1 2026, from $92.9 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $92.9 million in Q4 2025 to a low of $35.9 million in Q1 2022.
- A 5-year average of $55.5 million and a median of $52.7 million in 2024 frame the typical range for Revenue.
- Across the five-year window, Revenue decreased 6.81% in 2022 and jumped 30.09% in 2026, its largest moves.
- Tracing VCEL's Revenue over 5 years: stood at $52.7 million in 2022, then grew by 23.35% to $65.0 million in 2023, then gained by 15.97% to $75.4 million in 2024, then climbed by 23.27% to $92.9 million in 2025, then fell by 26.36% to $68.4 million in 2026.
- Business Quant data shows VCEL's Revenue at $68.4 million in Q1 2026, $92.9 million in Q4 2025, and $67.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Vericel | 2.29 Bn | 2.15 Bn | 49.27 Mn | 68.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.43 Mn |
| Dec 31, 2025 | 92.92 Mn |
| Sep 30, 2025 | 67.50 Mn |
| Jun 30, 2025 | 63.24 Mn |
| Mar 31, 2025 | 52.60 Mn |
| Dec 31, 2024 | 75.38 Mn |
| Sep 30, 2024 | 57.91 Mn |
| Jun 30, 2024 | 52.66 Mn |
| Mar 31, 2024 | 51.28 Mn |
| Dec 31, 2023 | 65.00 Mn |
| Sep 30, 2023 | 45.58 Mn |
| Jun 30, 2023 | 45.92 Mn |
| Mar 31, 2023 | 41.02 Mn |
| Dec 31, 2022 | 52.69 Mn |
| Sep 30, 2022 | 38.33 Mn |
| Jun 30, 2022 | 36.83 Mn |
| Mar 31, 2022 | 35.85 Mn |
| Dec 31, 2021 | 47.59 Mn |
| Sep 30, 2021 | 33.72 Mn |
| Jun 30, 2021 | 39.52 Mn |